Hormone Replacement Therapy Preserves Joint Implants
|
By HospiMedica International staff writers Posted on 23 Feb 2015 |
|
A new study reveals that hormone replacement therapy (HRT) is associated with an almost 40% decrease in the rate of revision surgery for hip and knee implants in women.
Researchers at the University of Oxford (United Kingdom), Universitat Autònoma de Barcelona (UAB; Spain), and other institutions conducted a study of 24,733 women who underwent primary total knee arthroplasty (TKA) or total hip arthroplasty (THA) to examine if HRT could reduce osteolysis and subsequent prosthesis loosening, the most common cause for revision surgery. The researchers explored associations with HRT use for over a year, adherence, and cumulative use and revision risk.
The results showed that the hazard ratio for implant failure fell to 0.62 after six months among HRT users. The risk reduction fell even further, reaching 0.48 for those who continued on HRT for at least a year. The results also showed that higher adherence and therapy duration were associated with further reductions in revision rates, but that preoperative HRT appeared unrelated to implant survival. The study was published in the March 2015 issue of Annals of the Rheumatic Diseases.
“Animal studies have suggested that estrogen deficiency exerts a negative influence on bone tissue around knee implants, while HRT minimizes periprosthetic bone loss and improves bone ingrowth around the implant,” concluded lead author Nigel Arden, MD, of the University of Oxford, and colleagues. “The findings that significant reductions in revision risk were seen among HRT users are encouraging for the research of antiresorptive agents that might improve outcomes following total joint replacement surgery in the future.”
The most common reason for joint replacement failure in the first year post implantation is due to aseptic loosening, which can result from osteolysis in the surrounding bone. While the mechanisms underlying loosening are still obscure, it is widely accepted that periprosthetic bone loss secondary to chronic inflammation and osteoclastic activity is the main pathway.
Related Links:
University of Oxford
Universitat Autònoma de Barcelona
Researchers at the University of Oxford (United Kingdom), Universitat Autònoma de Barcelona (UAB; Spain), and other institutions conducted a study of 24,733 women who underwent primary total knee arthroplasty (TKA) or total hip arthroplasty (THA) to examine if HRT could reduce osteolysis and subsequent prosthesis loosening, the most common cause for revision surgery. The researchers explored associations with HRT use for over a year, adherence, and cumulative use and revision risk.
The results showed that the hazard ratio for implant failure fell to 0.62 after six months among HRT users. The risk reduction fell even further, reaching 0.48 for those who continued on HRT for at least a year. The results also showed that higher adherence and therapy duration were associated with further reductions in revision rates, but that preoperative HRT appeared unrelated to implant survival. The study was published in the March 2015 issue of Annals of the Rheumatic Diseases.
“Animal studies have suggested that estrogen deficiency exerts a negative influence on bone tissue around knee implants, while HRT minimizes periprosthetic bone loss and improves bone ingrowth around the implant,” concluded lead author Nigel Arden, MD, of the University of Oxford, and colleagues. “The findings that significant reductions in revision risk were seen among HRT users are encouraging for the research of antiresorptive agents that might improve outcomes following total joint replacement surgery in the future.”
The most common reason for joint replacement failure in the first year post implantation is due to aseptic loosening, which can result from osteolysis in the surrounding bone. While the mechanisms underlying loosening are still obscure, it is widely accepted that periprosthetic bone loss secondary to chronic inflammation and osteoclastic activity is the main pathway.
Related Links:
University of Oxford
Universitat Autònoma de Barcelona
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Rapid Sepsis Test
SeptiCyte RAPID
Tourniquet System
heidi– mein Tourniquet
Latest Surgical Techniques News
- 3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
- CE-Marked Ultrasonic Shears Streamline Breast and Thyroid Surgery
- Small Cryoprobe Outperforms Forceps in Lung Biopsy Trial
- Natural Bypass Score May Guide Care in Chronic Coronary Blockages
- Navigation Instruments Cleared for Posterior Cervical Fusion Procedures
- Bioengineered Heart Patch Improves Cardiac Function in Advanced Heart Failure
- Fracture Plating System Combines Anatomical Fit with Streamlined Instrumentation
- Surgical Robotic System Gains CE Mark for Minimally Invasive Procedures
- Pink Noise Stimulation Approach Could Support Safer Anesthesia
- BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures
- Anesthesia-Sparing System Targets Faster Ureteral Stone Treatment
- Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
- FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
- Intravascular Lithotripsy Catheter Advances Treatment of Calcified Coronary Disease
- Handheld AI Endomicroscope Enables Real-Time Precancer Detection at Point of Care
- Photoacoustic Imaging System Maps Hidden Nerves and Vessels in Robotic Laparoscopy
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read more
Critical Care
view channel
Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
Atrial fibrillation, an irregular and often rapid heart rhythm, is the most common arrhythmia in adults. Elective electrical cardioversion is frequently canceled on the day of treatment when patients revert... Read more
New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
Benign prostatic hyperplasia is a noncancerous enlargement of the prostate that can cause lower urinary tract symptoms and impair daily functioning. These symptoms erode sleep, productivity, and sexual... Read more
Bedside CSF Monitor Detects Early Infection in Fluid Drains
External drainage of cerebrospinal fluid (CSF) after traumatic brain injury, hydrocephalus, or hemorrhage carries a significant risk of infection. These infections can prolong intensive care, cause severe... Read more
Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
Cardiac arrhythmias, including slow and irregular heart rhythms, often require pacemakers that are surgically implanted. While effective, implants carry procedural risks and long-term device maintenance burdens.... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
Point of Care
view channel
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read more
Business
view channel
Endologix Adds FDA-Cleared Peripheral Thrombectomy System
Endologix (Santa Rosa, CA, USA) has acquired the Pounce Thrombectomy System from Surmodics, with the transaction closing on May 18, 2026. The FDA-cleared system is indicated for the non-surgical removal... Read more
